NO20030868L - N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid - Google Patents

N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid

Info

Publication number
NO20030868L
NO20030868L NO20030868A NO20030868A NO20030868L NO 20030868 L NO20030868 L NO 20030868L NO 20030868 A NO20030868 A NO 20030868A NO 20030868 A NO20030868 A NO 20030868A NO 20030868 L NO20030868 L NO 20030868L
Authority
NO
Norway
Prior art keywords
benzenesulfonamide
piperazin
methoxyphenyl
dichloro
methoxy
Prior art date
Application number
NO20030868A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030868D0 (no
Inventor
Steven Mark Bromidge
Stephen Frederick Moss
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20030868D0 publication Critical patent/NO20030868D0/no
Publication of NO20030868L publication Critical patent/NO20030868L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20030868A 2000-08-31 2003-02-25 N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid NO20030868L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021450.2A GB0021450D0 (en) 2000-08-31 2000-08-31 Novel compounds
PCT/EP2001/009927 WO2002018358A1 (en) 2000-08-31 2001-08-27 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide

Publications (2)

Publication Number Publication Date
NO20030868D0 NO20030868D0 (no) 2003-02-25
NO20030868L true NO20030868L (no) 2003-04-04

Family

ID=9898634

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030868A NO20030868L (no) 2000-08-31 2003-02-25 N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid

Country Status (16)

Country Link
US (1) US20040034036A1 (xx)
EP (1) EP1313720A1 (xx)
JP (1) JP2004507530A (xx)
KR (1) KR20030024919A (xx)
CN (1) CN1449391A (xx)
AU (1) AU2001284041A1 (xx)
BR (1) BR0113650A (xx)
CA (1) CA2420935A1 (xx)
CZ (1) CZ2003579A3 (xx)
GB (1) GB0021450D0 (xx)
HU (1) HUP0300863A2 (xx)
IL (1) IL154675A0 (xx)
MX (1) MXPA03001783A (xx)
NO (1) NO20030868L (xx)
PL (1) PL361300A1 (xx)
WO (1) WO2002018358A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204720D0 (en) * 2002-02-28 2002-04-17 Glaxo Group Ltd Novel use
WO2003080580A2 (en) * 2002-03-27 2003-10-02 Glaxo Group Limited Quinoline derivatives and their use as 5-ht6 ligands
CN1826322B (zh) 2003-07-22 2012-04-18 艾尼纳制药公司 用于预防和治疗相关病症而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物
WO2007076875A2 (en) * 2006-01-06 2007-07-12 Aarhus Universitet Compounds acting on the serotonin transporter
EP2120950B1 (en) * 2007-03-21 2012-07-04 Glaxo Group Limited Use of quinoline derivatives in the treatment of pain
EP2508177A1 (en) 2007-12-12 2012-10-10 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
CN105085436B (zh) 2014-04-19 2019-08-16 广东东阳光药业有限公司 磺酰胺类衍生物及其在药物上的应用
AU2016276966A1 (en) 2015-06-12 2018-01-18 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of REM sleep behavior disorder
TW201720439A (zh) 2015-07-15 2017-06-16 Axovant Sciences Gmbh 用於預防及治療與神經退化性疾病相關的幻覺之作為5-ht2a血清素受體的二芳基及芳基雜芳基脲衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0003073A3 (en) * 1997-07-11 2002-10-28 Smithkline Beecham Plc Benzenesulfonamide derivatives, process for producing them and their use as medicines
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
KR20030024919A (ko) 2003-03-26
JP2004507530A (ja) 2004-03-11
US20040034036A1 (en) 2004-02-19
CN1449391A (zh) 2003-10-15
IL154675A0 (en) 2003-09-17
WO2002018358A1 (en) 2002-03-07
CA2420935A1 (en) 2002-03-07
HUP0300863A2 (hu) 2003-09-29
NO20030868D0 (no) 2003-02-25
AU2001284041A1 (en) 2002-03-13
MXPA03001783A (es) 2003-06-04
GB0021450D0 (en) 2000-10-18
CZ2003579A3 (cs) 2003-09-17
EP1313720A1 (en) 2003-05-28
PL361300A1 (en) 2004-10-04
BR0113650A (pt) 2004-02-10

Similar Documents

Publication Publication Date Title
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
MX242679B (es) Antranilamidas insecticidas.
FI20000004A0 (fi) Flavonoidilääke...
DE50114386D1 (de) Ng
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
NO20030868D0 (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
CH695519A5 (de) Sperrstromthyristor.
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
AT500246B8 (de) Chokerring
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
ATA17542000A (de) Hydraulikzylinder
ATA11602000A (de) Sonnenstandsnachführungssystem
ATA12252000A (de) Regensinkkasten
ATA19392000A (de) Kippflügelflugzeug
ATA21172000A (de) Hackbrett
PT9613T (pt) Vysor 3 d
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
UA3773S (uk) Шрифт
ITRC20000004V0 (it) Deodorante - souvenir "i calandreddhi"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application